# E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA

Page: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e123-upadacitinib-for-giant-cell-arteritis-select-gca
Text version: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e123-upadacitinib-for-giant-cell-arteritis-select-gca.md
Podcast: [The Evidence Based Rheumatology Podcast](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175)
Published: 2025-04-30T15:33:13+00:00
Episode link: https://msputman.podbean.com/e/e123-upadacitinib-for-giant-cell-arteritis-select-gca/
Audio file: https://mcdn.podbean.com/mf/web/fjeegi8sd278rqhk/e123.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e123-upadacitinib-for-giant-cell-arteritis-select-gca
Duration seconds: 1093

## Resource

Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e123-upadacitinib-for-giant-cell-arteritis-select-gca/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e123-upadacitinib-for-giant-cell-arteritis-select-gca.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.